Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics-Reference-Cited by-同舟云学术

Orexin-A Levels in Relation to the Risk of Metabolic Syndrome in Patients with Schizophrenia Taking Antipsychotics

Author:

Chen Po-Yu¹²³,Chen Chun-Hsin⁴⁵,Chang Chin-Kuo³⁶,Kao Chung-Feng⁷,Lu Mong-Liang⁴⁵,Lin Shih-Ku²⁴,Huang Ming-Chyi²⁴⁸,Hwang Ling-Ling¹⁹,Mondelli Valeria³

Affiliation:

1. Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan

2. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan

3. Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, United Kingdom

4. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taiwan

5. Department of Psychiatry, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan

6. Department of Health and Welfare, University of Taipei, Taipei, Taiwan

7. Department of Agronomy, College of Agriculture & Natural Resources, National Chung-Hsing University, Taichung, Taiwan

8. Psychiatric Research Center, Taipei Medical University Hospital

9. Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Funder

Ministry of Science and Technology, Taiwan

Taipei City Government, Taiwan

Taipei Institute of Pathology, Taiwan

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Link

Reference46 articles.

4. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women;Baranowska;Neuro Endocrinol Lett,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献